It’s the Documentation, Dentists
Dentists are skilled at performing exams to assess candidacy for oral appliance therapy. However, challenges arise when detailing the findings in SOAP notes format for medical insurers.
Dentists are skilled at performing exams to assess candidacy for oral appliance therapy. However, challenges arise when detailing the findings in SOAP notes format for medical insurers.
UnitedHealthcare’s updated medical policy for obstructive and central sleep apnea establishes oral appliance therapy as a prerequisite therapy for surgical treatment in adult patients with moderate to severe OSA.
CPT codes released in January 2022 have implications for sleep software that scales remote physiologic monitoring treatment management.
Dog eat your patient’s oral appliance? A few simple solutions can protect your patients’ sleep apnea therapy investments.
Read MoreSomnoMed announced Nexus Dental Systems as its preferred partner to offer sleep dentistry training and medical billing for OAT in the US Department of Defense, Department of Veterans Affairs, and commercial market segments.
Read MoreOral appliances for sleep apnea are not the only device or service dental sleep medicine practitioners offer that patients’ medical insurance could cover.
Read MoreDental sleep medicine practitioners can help senior adults who want to use their Medicare benefits overcome common therapy challenges.
Read More“This is a big win for patients suffering from insomnia,” says Patty Torr, Idorsia US president and general manager, in a release.
Read MoreA patient filed a federal lawsuit challenging the unlawfulness of Colorado Medicaid’s prior authorization criteria for HETLIOZ coverage.
Read MoreCMS will review the panel’s recommendations, and the final rules will be published later in 2021.
Read MoreOptumRx will offer and administer standard pharmacy benefit coverage for members who choose to add the product to their formularies.
Read MoreServe You Rx will provide prescription benefit coverage of Somryst to their members as a standard offering on all formularies.
Read MoreHow much should it cost to be monitored at home or in a hospital sleep lab? That’s the question.
Read MoreThis positive coverage decision provides additional OSA patients who are unable to benefit from CPAP the opportunity to gain access to Inspire therapy.”
Read MoreA new strategic investor is investing $20 million in Pear Therapeutics, bringing the total Series D investment to $100 million.
Read MoreHighmark Blue Cross Blue Shield and its affiliates will provide coverage for the Respicardia Inc’s remedē System implantable therapy for central sleep apnea, effective immediately.
Read MoreHealth insurer Independence Blue Cross has removed its prior authorization requirement for home sleep apnea tests following a dialog initiated by Itamar Medical to increase access.
Read MoreThe integration features Quickscreen, which identifies patients who are pre-approved or who already have an existing CareCredit credit card.
Read More